Boon T - Search Results

1

The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.

Uyttenhove C, Godfraind C, Lethé B, Amar-Costesec A, Renauld JC, Gajewski TF, Duffour MT, Warnier G, Boon T, Van den Eynde BJ. Uyttenhove C, et al. Among authors: boon t. Int J Cancer. 1997 Jan 27;70(3):349-56. doi: 10.1002/(sici)1097-0215(19970127)70:3<349::aid-ijc17>3.0.co;2-a. Int J Cancer. 1997. PMID: 9033639 Free article.

2

Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.

Ma W, Germeau C, Vigneron N, Maernoudt AS, Morel S, Boon T, Coulie PG, Van den Eynde BJ. Ma W, et al. Among authors: boon t. Int J Cancer. 2004 May 1;109(5):698-702. doi: 10.1002/ijc.20038. Int J Cancer. 2004. PMID: 14999777 Free article.

3

A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.

Ma W, Vigneron N, Chapiro J, Stroobant V, Germeau C, Boon T, Coulie PG, Van den Eynde BJ. Ma W, et al. Among authors: boon t. Int J Cancer. 2011 Nov 15;129(10):2427-34. doi: 10.1002/ijc.25911. Epub 2011 Apr 20. Int J Cancer. 2011. PMID: 21207413 Free article.

4

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.

Lethé B, van den Eynde B, van Pel A, Corradin G, Boon T. Lethé B, et al. Among authors: boon t. Eur J Immunol. 1992 Sep;22(9):2283-8. doi: 10.1002/eji.1830220916. Eur J Immunol. 1992. PMID: 1381312

5

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.

Van den Eynde B, Lethé B, Van Pel A, De Plaen E, Boon T. Van den Eynde B, et al. Among authors: boon t. J Exp Med. 1991 Jun 1;173(6):1373-84. doi: 10.1084/jem.173.6.1373. J Exp Med. 1991. PMID: 1903428 Free PMC article.

6

Expression of mage genes by non-small-cell lung carcinomas.

Weynants P, Lethé B, Brasseur F, Marchand M, Boon T. Weynants P, et al. Among authors: boon t. Int J Cancer. 1994 Mar 15;56(6):826-9. doi: 10.1002/ijc.2910560612. Int J Cancer. 1994. PMID: 8119772

7

Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.

Gajewski TF, Fallarino F, Uyttenhove C, Boon T. Gajewski TF, et al. Among authors: boon t. J Immunol. 1996 Apr 15;156(8):2909-17. J Immunol. 1996. PMID: 8609411

8

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A.

Warnier G, Duffour MT, Uyttenhove C, Gajewski TF, Lurquin C, Haddada H, Perricaudet M, Boon T. Warnier G, et al. Among authors: boon t. Int J Cancer. 1996 Jul 17;67(2):303-10. doi: 10.1002/(SICI)1097-0215(19960717)67:2<303::AID-IJC24>3.0.CO;2-A. Int J Cancer. 1996. PMID: 8760603 Free article.

9

Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.

De Plaen E, Lurquin C, Lethé B, van der Bruggen P, Brichard V, Renauld JC, Coulie P, Van Pel A, Boon T. De Plaen E, et al. Among authors: boon t. Methods. 1997 Jun;12(2):125-42. doi: 10.1006/meth.1997.0462. Methods. 1997. PMID: 9184377 Review.

10

Tumor antigens recognized by T lymphocytes.

Van den Eynde BJ, Boon T. Van den Eynde BJ, et al. Among authors: boon t. Int J Clin Lab Res. 1997;27(2):81-6. doi: 10.1007/BF02912440. Int J Clin Lab Res. 1997. PMID: 9266277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page